These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 26237517)

  • 21. Differential expression of myosin heavy chain isoforms in the masticatory muscles of dystrophin-deficient mice.
    Spassov A; Gredes T; Gedrange T; Lucke S; Morgenstern S; Pavlovic D; Kunert-Keil C
    Eur J Orthod; 2011 Dec; 33(6):613-9. PubMed ID: 21187529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Structure of neuromuscular junctions and differentiation of striated muscle fibers of mdx mice after bone marrow stem cells therapy].
    Sokolova AV; Zenin VV; Mikhaĭlov VM
    Tsitologiia; 2010; 52(5):399-406. PubMed ID: 20586275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy.
    Marques MJ; Ferretti R; Vomero VU; Minatel E; Neto HS
    Muscle Nerve; 2007 Mar; 35(3):349-53. PubMed ID: 17143878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
    Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S
    Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanopatterned muscle cell patches for enhanced myogenesis and dystrophin expression in a mouse model of muscular dystrophy.
    Yang HS; Ieronimakis N; Tsui JH; Kim HN; Suh KY; Reyes M; Kim DH
    Biomaterials; 2014 Feb; 35(5):1478-86. PubMed ID: 24290810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recapitulating early development of mouse musculoskeletal precursors of the paraxial mesoderm
    Chal J; Al Tanoury Z; Oginuma M; Moncuquet P; Gobert B; Miyanari A; Tassy O; Guevara G; Hubaud A; Bera A; Sumara O; Garnier JM; Kennedy L; Knockaert M; Gayraud-Morel B; Tajbakhsh S; Pourquié O
    Development; 2018 Mar; 145(6):. PubMed ID: 29555813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multilineage Differentiation for Formation of Innervated Skeletal Muscle Fibers from Healthy and Diseased Human Pluripotent Stem Cells.
    Mazaleyrat K; Badja C; Broucqsault N; Chevalier R; Laberthonnière C; Dion C; Baldasseroni L; El-Yazidi C; Thomas M; Bachelier R; Altié A; Nguyen K; Lévy N; Robin JD; Magdinier F
    Cells; 2020 Jun; 9(6):. PubMed ID: 32585982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregnancy-induced amelioration of muscular dystrophy phenotype in mdx mice via muscle membrane stabilization effect of glucocorticoid.
    Shimizu-Motohashi Y; Asakura Y; Motohashi N; Belur NR; Baumrucker MG; Asakura A
    PLoS One; 2015; 10(3):e0120325. PubMed ID: 25775477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dystrophin delivery in dystrophin-deficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation.
    Ikezawa M; Cao B; Qu Z; Peng H; Xiao X; Pruchnic R; Kimura S; Miike T; Huard J
    Hum Gene Ther; 2003 Nov; 14(16):1535-46. PubMed ID: 14577915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flk-1+ adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice.
    Liu Y; Yan X; Sun Z; Chen B; Han Q; Li J; Zhao RC
    Stem Cells Dev; 2007 Oct; 16(5):695-706. PubMed ID: 17999592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells.
    Shoji E; Sakurai H; Nishino T; Nakahata T; Heike T; Awaya T; Fujii N; Manabe Y; Matsuo M; Sehara-Fujisawa A
    Sci Rep; 2015 Aug; 5():12831. PubMed ID: 26290039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A muscle fatigue-like contractile decline was recapitulated using skeletal myotubes from Duchenne muscular dystrophy patient-derived iPSCs.
    Uchimura T; Asano T; Nakata T; Hotta A; Sakurai H
    Cell Rep Med; 2021 Jun; 2(6):100298. PubMed ID: 34195678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Regeneration capacity of skeletal muscle].
    Wernig A
    Ther Umsch; 2003 Jul; 60(7):383-9. PubMed ID: 12956031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane.
    De Bari C; Dell'Accio F; Vandenabeele F; Vermeesch JR; Raymackers JM; Luyten FP
    J Cell Biol; 2003 Mar; 160(6):909-18. PubMed ID: 12629053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myogenesis modelled by human pluripotent stem cells: a multi-omic study of Duchenne myopathy early onset.
    Mournetas V; Massouridès E; Dupont JB; Kornobis E; Polvèche H; Jarrige M; Dorval ARL; Gosselin MRF; Manousopoulou A; Garbis SD; Górecki DC; Pinset C
    J Cachexia Sarcopenia Muscle; 2021 Feb; 12(1):209-232. PubMed ID: 33586340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of Induced Pluripotent Stem Cells From Patients With Duchenne Muscular Dystrophy and Their Induction to Cardiomyocytes.
    Hashimoto A; Naito AT; Lee JK; Kitazume-Taneike R; Ito M; Yamaguchi T; Nakata R; Sumida T; Okada K; Nakagawa A; Higo T; Kuramoto Y; Sakai T; Tominaga K; Okinaga T; Kogaki S; Ozono K; Miyagawa S; Sawa Y; Sakata Y; Morita H; Umezawa A; Komuro I
    Int Heart J; 2016; 57(1):112-7. PubMed ID: 26673445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death.
    Smith J; Goldsmith C; Ward A; LeDieu R
    Cell Death Differ; 2000 Nov; 7(11):1109-18. PubMed ID: 11139285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based Model.
    Choi IY; Lim H; Estrellas K; Mula J; Cohen TV; Zhang Y; Donnelly CJ; Richard JP; Kim YJ; Kim H; Kazuki Y; Oshimura M; Li HL; Hotta A; Rothstein J; Maragakis N; Wagner KR; Lee G
    Cell Rep; 2016 Jun; 15(10):2301-2312. PubMed ID: 27239027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy.
    Palladino M; Gatto I; Neri V; Straino S; Smith RC; Silver M; Gaetani E; Marcantoni M; Giarretta I; Stigliano E; Capogrossi M; Hlatky L; Landolfi R; Pola R
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2867-76. PubMed ID: 24072696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
    Yuasa K; Nakamura A; Hijikata T; Takeda S
    BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.